Vaxcyte (PCVX) Treasury Shares (2019 - 2020)

Vaxcyte (PCVX) has reported Treasury Shares for 7 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 1233.57% from the prior year.
• Treasury Shares rose to $3.3 million in Q1 2026 per PCVX's latest filing, from $2.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.3 million in Q1 2026 and bottomed at $175513.0 in Q1 2024.
• Historically, Treasury Shares has averaged $1.0 million across 5 years, with a median of $726940.0 in 2023.
• Annual changes were most pronounced in 2024 — Treasury Shares plunged 77.99% — and 2025, when it soared 1233.57%.
• Vaxcyte's Treasury Shares stood at $456766.0 in 2022, then jumped by 64.96% to $753462.0 in 2023, then slumped by 76.71% to $175513.0 in 2024, then jumped by 1233.57% to $2.3 million in 2025, then jumped by 42.27% to $3.3 million in 2026.
• Business Quant data shows PCVX's Treasury Shares at $3.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.1 million in Q3 2025.